<DOC>
	<DOCNO>NCT00884104</DOCNO>
	<brief_summary>The purpose study evaluate rate `` add-on '' solifenacin treatment persistency men active bladder symptom tamsulosin monotherapy 4 week .</brief_summary>
	<brief_title>A Study Evaluate Add Effect Solifenacin Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy 4 Weeks</brief_title>
	<detailed_description>This multi-center study evaluate efficacy , safety , persistency solifenacin treatment male patient persistent OAB symptom urinary frequency urgency with/without urgency incontinence receive tamsulosin monotherapy LUTS stable dose 4 week real life practice . Also proportion patient predictive factor persistent OAB symptom tamsulosin monotherapy investigate .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>IPSS ≥ 12 Symptoms OAB verify V8 ( ≥8 ) Symptoms OAB verify screen 3day bladder diary , define : Mean urinary frequency ≥8 times/24 hour Mean number micturitionrelated urgency episode ≥3 episode/24 hour ( Urinary Sensation Scale rating ≥3 mark corresponding micturition bladder diary ) Treatment within 14 day precede treatment alpha blocker drug A known history bladder outlet obstruction due : bladder neck contracture , clinical suspicion prostate carcinoma , mullerian duct cyst , urethral obstruction due stricture/valves/sclerosis urethral tumor</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Solifenacin</keyword>
	<keyword>Tamsulosin</keyword>
	<keyword>OAB</keyword>
</DOC>